INFLUENCE OF SCHOOL CLOSURE ON THE INCIDENCE OF VIRAL RESPIRATORY DISEASES AMONG CHILDREN AND ON HEALTH CARE UTILIZATION

We evaluated the effect of school closure on the occurrence of respiratory infection among children ages 6–12 years and its impact on health care services. During this period, there were significant decreases in the diagnoses of respiratory infections (42%), visits to physician (28%) and emergency departments (28%) and medication purchases (35%). The present study provides quantitative data to support school closure during an influenza pandemic.

[1]  B. Uthman,et al.  Vagus nerve stimulation therapy for partial-onset seizures , 1998, Neurology.

[2]  K. Neuzil,et al.  Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. , 2002, Archives of pediatrics & adolescent medicine.

[3]  Basim M. Uthman,et al.  Vagus Nerve Stimulation for the Treatment of Medically Intractable Seizures: Results of a 1-Year Open-Extension Trial , 1996 .

[4]  K. Yamanishi,et al.  IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUM , 1988, The Lancet.

[5]  T. F. Smith,et al.  Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system , 1997, Journal of clinical microbiology.

[6]  A. Safdar,et al.  Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  W. Tarver,et al.  Treatment of Refractory Partial Seizures: Preliminary Results of a Controlled Study , 1992, Pacing and clinical electrophysiology : PACE.

[8]  E. Major,et al.  Progressive multifocal leukoencephalopathy in HIV‐1-infected children , 1992, AIDS.

[9]  T. File,et al.  Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Camfield,et al.  Vagal nerve stimulation for treatment of children with epilepsy. , 1999, The Journal of pediatrics.

[11]  J. Murphy,et al.  Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group. , 1999, The Journal of pediatrics.

[12]  K. Hoppu,et al.  Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life , 1993, Clinical pharmacology and therapeutics.

[13]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[14]  D. Kaufman,et al.  Fluconazole prophylaxis against fungal colonization and infection in preterm infants. , 2001, The New England journal of medicine.

[15]  J. Kai.  What worries parents when their preschool children are acutely ill, and why: a qualitative study , 1996, BMJ.

[16]  J. Fox,et al.  Case-to-case intervals of rhinovirus and influenza virus infections in households. , 1988, The Journal of infectious diseases.

[17]  M. A. Martin,et al.  National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. , 1998, Diagnostic microbiology and infectious disease.

[18]  M. Lederman,et al.  Placebo-controlled trial of prednisone in advanced HIV-1 infection , 2001, AIDS.

[19]  J. Hunter,et al.  Progressive multifocal leukoencephalopathy in an HIV-infected child , 1997, Neuroradiology.

[20]  J. Murphy,et al.  Adverse events in children receiving intermittent left vagal nerve stimulation. , 1998, Pediatric neurology.

[21]  N. Cox,et al.  Influenza pandemic preparedness plan for the United States. , 1997, The Journal of infectious diseases.

[22]  J. P. Davis,et al.  Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. , 1993, JAMA.

[23]  S. Wyke,et al.  Respiratory illness in children: what makes parents decide to consult? , 1990, The British journal of general practice : the journal of the Royal College of General Practitioners.

[24]  B. Uthman,et al.  Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group. , 1996, Archives of neurology.

[25]  R. Facklam,et al.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci , 1996, Journal of clinical microbiology.

[26]  Toshihiko Mori,et al.  Reactivation of varicella-zoster virus in facial palsy associated with infectious mononucleosis. , 2002, The Pediatric infectious disease journal.

[27]  T. W. Smith,et al.  Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? , 1998, The American journal of medicine.

[28]  K. Edwards,et al.  Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. , 2002, The Journal of infectious diseases.

[29]  B. Yoder,et al.  Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.

[30]  E. Bebin,et al.  Efficacy of Vagal Nerve Stimulation in Children with Medically Refractory Epilepsy , 2000, Neurosurgery.

[31]  C. Okeahialam,et al.  A community outbreak of invasive and non-invasive group A beta-haemolytic streptococcal disease in a town in South Wales , 1998, Epidemiology and Infection.

[32]  E F Mitchel,et al.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. , 2000, The New England journal of medicine.

[33]  W. Koch.  Fifth (human parvovirus) and sixth (herpesvirus 6) diseases , 2001, Current opinion in infectious diseases.

[34]  L. Corey,et al.  Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  P. Kale-Pradhan,et al.  Therapeutic Dilemma of Fluconazole Prophylaxis in Intensive Care , 2002, The Annals of pharmacotherapy.

[36]  J. Leblanc,et al.  Giant hydatid lung cysts in the Canadian northwest: outcome of conservative treatment in three children. , 1993, Journal of pediatric surgery.

[37]  R. Couch,et al.  Interpandemic influenza in the Houston area, 1974-76. , 1978, The New England journal of medicine.

[38]  William H. McNeill,et al.  America's Forgotten Pandemic: The Influenza of 1918 , 1991 .

[39]  M. Turgut.  Intracranial hydatidosis in Turkey: its clinical presentation, diagnostic studies, surgical management, and outcome. A review of 276 cases , 2001, Neurosurgical Review.

[40]  Evelyn S. Tecoma,et al.  Vagus nerve stimulation for medication-resistant generalized epilepsy , 1999, Neurology.

[41]  B. Padgett,et al.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. , 1973, The Journal of infectious diseases.

[42]  R. Kuzniecky,et al.  Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. , 1994, Epilepsia.

[43]  M. Khaldi,et al.  Brain hydatidosis: report on 117 cases , 2000, Child's Nervous System.

[44]  G. Blennow,et al.  Vagus Nerve Stimulation in 16 Children with Refractory Epilepsy , 1998, Epilepsia.

[45]  H. Miyoshi,et al.  Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection , 1999, Brain and Development.

[46]  J. Quinn,et al.  Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children , 2002, The Pediatric infectious disease journal.

[47]  J P Fox,et al.  Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. , 1982, American journal of epidemiology.

[48]  P. Phillips-Howard,et al.  CNS Adverse Events Associated With Antimalarial Agents , 1995, Drug safety.

[49]  E. Ben-Menachem,et al.  Vagus Nerve Stimulation for Treatment of Partial Seizures: 1. A Controlled Study of Effect on Seizures , 1994, Epilepsia.

[50]  C. Grose,et al.  Chickenpox and the geniculate ganglion: facial nerve palsy, Ramsay Hunt syndrome and acyclovir treatment. , 2002, The Pediatric infectious disease journal.

[51]  S. Kaplan,et al.  Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children , 2002, The Pediatric infectious disease journal.

[52]  I. Pedrosa,et al.  Hydatid disease: radiologic and pathologic features and complications. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[53]  I M Longini,et al.  Estimating household and community transmission parameters for influenza. , 1982, American journal of epidemiology.

[54]  R. Snow,et al.  Indicators of life-threatening malaria in African children. , 1995, The New England journal of medicine.

[55]  J. Cosín,et al.  Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. , 2001, AIDS.

[56]  A. Lazzarin,et al.  Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  M. Libman,et al.  Prevalence and Antifungal Susceptibility of 442Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada , 2001, Journal of Clinical Microbiology.

[58]  J. Collazos,et al.  Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. , 1999, AIDS.

[59]  M. A. El-Atta,et al.  Magnetic resonance imaging of simple and infected hydatid cysts of the brain. , 2001, Magnetic resonance imaging.

[60]  R. Kuzniecky,et al.  Vagus Nerve Stimulation for Treatment of Partial Seizures: 3. Long‐Term Follow‐Up on First 67 Patients Exiting a Controlled Study , 1994, Epilepsia.

[61]  I. Pyykkö,et al.  Paediatric facial paralysis caused by Lyme borreliosis: a prospective and retrospective analysis. , 1998, Scandinavian journal of infectious diseases.

[62]  D. Lewall.  Hydatid disease: biology, pathology, imaging and classification. , 1998, Clinical radiology.

[63]  H. Kock,et al.  Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems , 1998, World Journal of Surgery.

[64]  M. Smyth,et al.  Complications of chronic vagus nerve stimulation for epilepsy in children. , 2003, Journal of neurosurgery.

[65]  R. Carrea,et al.  Surgical treatment of hydatid cysts of the central nervous system in the pediatric age (Dowling's technique). , 1975, Child's brain.

[66]  J. Gaynor,et al.  Pediatric pacemaker infections: twenty years of experience. , 2002, The Journal of thoracic and cardiovascular surgery.

[67]  K. Hecox,et al.  Interscapular Placement of a Vagal Nerve Stimulator Pulse Generator for Prevention of Wound Tampering , 2002, Pediatric Neurosurgery.

[68]  R. Chapman.  Candida infections in the neonate , 2003, Current opinion in pediatrics.

[69]  J. Sobel,et al.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  J. Drazen.  SARS--looking back over the first 100 days. , 2003, The New England journal of medicine.

[71]  R. Robinson,et al.  Vagal Nerve Stimulation in Epileptic Encephalopathies , 1999, Pediatrics.

[72]  R. Kaul,et al.  Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. , 1997, The American journal of medicine.

[73]  D. Malone,et al.  Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  P. Crumrine.  Vagal nerve stimulation in children. , 2000, Seminars in pediatric neurology.

[75]  N. Hato,et al.  Bell Palsy and Herpes Simplex Virus: Identification of Viral DNA in Endoneurial Fluid and Muscle , 1996, Annals of Internal Medicine.

[76]  F. Schildberg,et al.  Klebsiella pneumoniae Necrotizing F asciitis Associated w ith D iabetes a nd L iver C irrhosis , 2000 .

[77]  Lippincott Williams Wilkins,et al.  A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures , 1995, Neurology.

[78]  T. Hulsey,et al.  Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. , 2001, Pediatrics.

[79]  A. Imparato,et al.  Electrode complications in patients with permanent cardiac pacemakers. Ten years' experience. , 1972, Archives of surgery.

[80]  A. Vaheri,et al.  Detection of Human Herpesvirus 6 and Varicella-Zoster Virus in Tear Fluid of Patients with Bell's Palsy by PCR , 2000, Journal of Clinical Microbiology.

[81]  S. Jäämaa,et al.  Varicella zoster and Borrelia burgdorferi are the main agents associated with facial paresis, especially in children. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[82]  R. O'Loughlin.  Epidemiology of Invasive Group A streptococcus Disease in the United States, 2000-2003. , 2005 .

[83]  A. Shirom,et al.  Reforming the Israeli health system: findings of a 3-year evaluation. , 2001, Health policy.